These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 31243527)

  • 1. Oxaliplatin induces prostaglandin E2 release in vascular endothelial cells.
    Matsunuma S; Handa S; Kamei D; Yamamoto H; Okuyama K; Kato Y
    Cancer Chemother Pharmacol; 2019 Aug; 84(2):345-350. PubMed ID: 31243527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rate of vasoconstrictor prostanoids released by endothelial cells depends on cyclooxygenase-2 expression and prostaglandin I synthase activity.
    Camacho M; López-Belmonte J; Vila L
    Circ Res; 1998 Aug; 83(4):353-65. PubMed ID: 9721692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between prostaglandin E2 and vascular endothelial growth factor (VEGF) in angiogenesis in human vascular endothelial cells.
    Tamura K; Sakurai T; Kogo H
    Vascul Pharmacol; 2006 Jun; 44(6):411-6. PubMed ID: 16651031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrasting effects of peroxisome-proliferator-activated receptor (PPAR)gamma agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1beta-stimulated rat chondrocytes: evidence for PPARgamma-independent inhibition by 15-deoxy-Delta12,14prostaglandin J2.
    Bianchi A; Moulin D; Sebillaud S; Koufany M; Galteau MM; Netter P; Terlain B; Jouzeau JY
    Arthritis Res Ther; 2005; 7(6):R1325-37. PubMed ID: 16277686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of ADAM17 inhibits cell proliferation and increases oxaliplatin sensitivity in HCT-8 colorectal cancer through EGFR-PI3K-AKT activation.
    Zhang Q; Wang C; Han X; Yang G; Ge Z; Zhang G
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2333-2339. PubMed ID: 29964008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The induction of cyclooxygenase-2 in IL-1beta-treated endothelial cells is inhibited by prostaglandin E2 through cAMP.
    Akarasereenont P; Techatrisak K; Chotewuttakorn S; Thaworn A
    Mediators Inflamm; 1999; 8(6):287-94. PubMed ID: 10815617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive feedback regulation of COX-2 expression by prostaglandin metabolites.
    Vichai V; Suyarnsesthakorn C; Pittayakhajonwut D; Sriklung K; Kirtikara K
    Inflamm Res; 2005 Apr; 54(4):163-72. PubMed ID: 15883739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 15-Deoxy-Delta12,14-prostaglandin J2 inhibits IL-1beta-induced cyclooxygenase-2 expression in mesangial cells.
    Sawano H; Haneda M; Sugimoto T; Inoki K; Koya D; Kikkawa R
    Kidney Int; 2002 Jun; 61(6):1957-67. PubMed ID: 12028436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon gamma induces prostaglandin G/H synthase-2 through an autocrine loop via the epidermal growth factor receptor in human bronchial epithelial cells.
    Asano K; Nakamura H; Lilly CM; Klagsbrun M; Drazen JM
    J Clin Invest; 1997 Mar; 99(5):1057-63. PubMed ID: 9062364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxaliplatin (L-OHP) treatment of human myeloma cells induces in vitro growth inhibition and apoptotic cell death.
    Tassone P; Tagliaferri P; Galea E; Palmieri C; Bonelli P; Martelli ML; Tuccillo F; Turco MC; Venuta S
    Eur J Cancer; 2002 May; 38(8):1141-7. PubMed ID: 12008204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and toxicodynamic evaluation of oxaliplatin-induced neuropathy and hematological toxicity in rats.
    Ito Y; Kobuchi S; Shimizu R; Katsuyama Y
    Cancer Chemother Pharmacol; 2018 Jan; 81(1):155-161. PubMed ID: 29164296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of noxious stimulus-induced spinal prostaglandin E2 release by flurbiprofen enantiomers: a microdialysis study.
    Geisslinger G; Muth-Selbach U; Coste O; Vetter G; Schrödter A; Schaible HG; Brune K; Tegeder I
    J Neurochem; 2000 May; 74(5):2094-100. PubMed ID: 10800954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between nitric oxide and cyclooxygenase pathways in endothelial cells.
    Vassalle C; Domenici C; Lubrano V; L'Abbate A
    J Vasc Res; 2003; 40(5):491-9. PubMed ID: 14583660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inhibitory effects of mercaptoalkylguanidines on cyclo-oxygenase activity.
    Zingarelli B; Southan GJ; Gilad E; O'Connor M; Salzman AL; Szabó C
    Br J Pharmacol; 1997 Feb; 120(3):357-66. PubMed ID: 9031736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NSAIDS inhibit the IL-1 beta-induced IL-6 release from human post-mortem astrocytes: the involvement of prostaglandin E2.
    Blom MA; van Twillert MG; de Vries SC; Engels F; Finch CE; Veerhuis R; Eikelenboom P
    Brain Res; 1997 Nov; 777(1-2):210-8. PubMed ID: 9449430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High concentration of oxaliplatin may be a risk factor for vascular pain.
    Matsunuma S; Handa S; Yamamoto H; Okuyama K; Yoshimoto K; Kato Y
    J Clin Pharm Ther; 2022 Apr; 47(4):462-468. PubMed ID: 34743376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metronomic 5-fluorouracil, oxaliplatin and irinotecan in colorectal cancer.
    Fioravanti A; Canu B; Alì G; Orlandi P; Allegrini G; Di Desidero T; Emmenegger U; Fontanini G; Danesi R; Del Tacca M; Falcone A; Bocci G
    Eur J Pharmacol; 2009 Oct; 619(1-3):8-14. PubMed ID: 19695243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The peroxisome proliferator-activated receptor gamma ligand 15-deoxy-Delta12,14-prostaglandin J2 induces vascular endothelial growth factor in the hormone-independent prostate cancer cell line PC 3 and the urinary bladder carcinoma cell line 5637.
    Haslmayer P; Thalhammer T; Jäger W; Aust S; Steiner G; Ensinger C; Obrist P
    Int J Oncol; 2002 Oct; 21(4):915-20. PubMed ID: 12239635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PGE2 induces its own secretion in vitro by bovine 270-day placenta but not by 200-day placenta.
    Weems YS; Lammoglia MA; Lewis AW; Randel RD; Sasser RG; Morita I; Weems CW
    Prostaglandins Other Lipid Mediat; 1999 Jun; 57(4):189-205. PubMed ID: 10402214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of oxaliplatin-resistant gastric cancer organoids: importance of myoferlin in the acquisition of oxaliplatin resistance.
    Harada K; Sakamoto N; Ukai S; Yamamoto Y; Pham QT; Taniyama D; Honma R; Maruyama R; Takashima T; Ota H; Takemoto Y; Tanabe K; Ohdan H; Yasui W
    Gastric Cancer; 2021 Nov; 24(6):1264-1277. PubMed ID: 34272617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.